Effectiveness of Using the AOPT‐LTL Technique for the Treatment of Melasma: A Clinical Study
Skin Research and Technology · 2026-04 · 32 (4)
DOI: 10.1111/srt.70347 ↗At a glance
Klinische Studie in Skin Research and Technology, published online on 2026-04-07. Written by Qingmei Jin and 6 co-authors. Institution: Department of Dermatology, Yanbian University Hospital, Yanji, China. Major MEDLINE topics: Melanosis, Low-Level Light Therapy. 28 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Melasma is a common acquired pigmentation disorder, with a high incidence rate in women. Owing to the complex pathogenesis of melasma, there is currently no unified treatment. Advanced optimal pulse technology with low energy, three pulses, and long pulse width (AOPT‐LTL) is a treatment technique based on the photomodulatory effect of optimal pulse technology (OPT), which has been used in the treatment of sensitive skin and rosacea.
Aims
To evaluate the efficacy and safety of AOPT‐LTL for the treatment of melasma.
Methods
Twenty‐five Chinese females with melasma were enrolled. AOPT‐LTL treatments were delivered at 2‐week intervals. The melasma area and severity index (MASI) score, clinician erythema assessment (CEA) score, clinical efficacy, incidence of adverse reactions, and patient satisfaction were compared between baseline and post‐treatment.
Results
All patients were treated and followed up. After 1 month of treatment, skin inflammation decreased, and pigmentation started to fade. With continued treatment, the inflammation progressively reduced, the affected area became smaller, and pigmentation lightened further. After the first course of treatment, 19 patients had a declined rate of MASI (MDR) >20%, and the effective rate was 76%. At the end of treatment, the MASI score and CEA score of all patients decreased significantly. Moreover, the MDR of all patients was >20%, and the effective rate of treatment was 100%. During treatment, all patients had no obvious adverse reactions, no recurrence after follow‐up for 3 months, and patient satisfaction was high.
Conclusions
AOPT‐LTL is effective and safe for treating melasma.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Dermatology, Yanbian University Hospital, Yanji, China.
- Department of Medical Cosmetology, Yanbian University Hospital, Yanji, China.
- Department of Dermatology, Suzhou Mylike Cosmetic Hospital, Suzhou, China.
ORCID profiles: Qingmei Jin
Cite
APA
Jin, Q., Dong, R., Zhi, J., Nan, M., Pi, L., Jin, Z., & Jin, C. (2026). Effectiveness of Using the AOPT‐LTL Technique for the Treatment of Melasma: A Clinical Study. Skin Research and Technology, 32(4). https://doi.org/10.1111/srt.70347
Vancouver
Jin Q, Dong R, Zhi J, Nan M, Pi L, Jin Z, et al. Effectiveness of Using the AOPT‐LTL Technique for the Treatment of Melasma: A Clinical Study. Skin Research and Technology. 2026;32(4). doi:10.1111/srt.70347
BibTeX
@article{Jin2026,
author = {Jin, Qingmei and Dong, Richeng and Zhi, Jiahui and Nan, Meilan and Pi, Longquan and Jin, Zhehu and Jin, Chenglong},
title = {Effectiveness of Using the AOPT‐LTL Technique for the Treatment of Melasma: A Clinical Study},
journal = {Skin Research and Technology},
year = {2026},
volume = {32},
number = {4},
doi = {10.1111/srt.70347}
}
EUVIMED